Bioequivalence Study of Patches With Different Release Profiles

A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Mercilon.

NCT00236782 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO EVRA (a Transdermal Contraceptive Patch)

NCT00258076 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study of the Oral Contraceptive Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.

NCT00709189 ·Status: COMPLETED ·Phase: PHASE1

Study Investigating the Efficacy and Safety of a Contraceptive Patch for 13 Cycles

NCT00910637 ·Status: COMPLETED ·Phase: PHASE3

Birth Control Patch Study

NCT00984789 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Exposure of Norelgestromin and Ethinyl Estradiol From Commercial Lots of EVRA (a Transdermal Contraceptive Patch Manufactured by LOHMANN Therapie-Systeme) and CILEST (an Oral Contraceptive)

NCT00258063 ·Status: COMPLETED ·Phase: PHASE1

A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil.

NCT00236795 ·Status: COMPLETED ·Phase: PHASE3

Bioequivalence Study of the Oral Contraceptive (OC) Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.

NCT00709644 ·Status: COMPLETED ·Phase: PHASE1

An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of Norelgestromine and Ethinyl Estradiol

NCT00307632 ·Status: COMPLETED ·Phase: PHASE4

A Study of Efficacy and Safety With the Transdermal Contraceptive System.

NCT00236769 ·Status: COMPLETED ·Phase: PHASE3

An Open-label, Multicentre Study on Preference and Satisfaction of Canadian Women for the Transdermal Contraceptive Patch vs. Previous Primary Contraceptive Method

NCT00653016 ·Status: COMPLETED ·Phase: PHASE4

An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional Regimen

NCT00320580 ·Status: COMPLETED ·Phase: PHASE2

Study Comparing Two Manufacturing Processes for Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg (LNG/EE) in Healthy, Cycling Women

NCT00319163 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Women's Experience With EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception.

NCT00261482 ·Status: COMPLETED ·Phase: PHASE4

A Comparative Pharmacokinetic Study of ORTHO EVRA (a Transdermal Contraceptive Patch) and CILEST (an Oral Contraceptive) in Healthy Female Volunteers

NCT00254865 ·Status: COMPLETED ·Phase: PHASE1

Transdermal Contraceptive Patch - Endometrial Effects Study

NCT00896571 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception

NCT02021097 ·Status: UNKNOWN ·Phase: PHASE3

Study of Safety and Efficacy of an Oral Contraceptive

NCT00391807 ·Status: COMPLETED ·Phase: PHASE3

A Trial in Healthy Female Subjects to Compare the Pharmacokinetics of Ethinyl Estradiol of NuvaRing®, a Contraceptive Patch (EVRA(TM)) and an Oral Contraceptive (Microgynon® 30) (Study 34237 (P06650)) (COMPLETED)

NCT01044056 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential

NCT06672016 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control

NCT00377988 ·Status: COMPLETED

Study Evaluating the Bioequivalence of Levonorgestrel/Ethinyl Estradiol Combinations in Cycling Women

NCT00447863 ·Status: WITHDRAWN ·Phase: PHASE1

Investigation of Three Contraceptive Hormone Patches in Regard to Inhibition of Ovulation Following Application Over 3 Treatment Cycles in Healthy, Young Women.

NCT01204190 ·Status: COMPLETED ·Phase: PHASE2

A Multi-center, Open-label, Randomized, Parallel Group Study to Evaluate Pharmacokinetic Profile, Effects on the Mechanisms of Contraceptive Efficacy and Safety of Two Progestin-only Patches Containing Different Doses of Levonorgestrel (LNG)

NCT01166412 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product

NCT04230070 ·Status: COMPLETED ·Phase: PHASE1